Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24892551)

1.

Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.

Okabe H, Delgado E, Lee JM, Yang J, Kinoshita H, Hayashi H, Tsung A, Behari J, Beppu T, Baba H, Monga SP.

PLoS One. 2014 Jun 3;9(6):e98817. doi: 10.1371/journal.pone.0098817. eCollection 2014.

2.

Lower serum soluble-EGFR is a potential biomarker for metastasis of HCC demonstrated by N-glycoproteomic analysis.

Hu H, Gao L, Wang C, Li Y, Ma H, Chen L, Qin J, Liu B, Liu Y, Liang C.

Discov Med. 2015 May;19(106):333-41.

3.

Localized LECT2 amyloidosis of the adrenal gland with coexisting MGUS: a diagnostic challenge.

Angell TE, Swaika A, Sood N, Goldfarb M, Siddiqi I, Ailawadhi S.

Ann Hematol. 2015 Jun 7. [Epub ahead of print] No abstract available.

PMID:
26048244
4.

Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.

Delgado E, Okabe H, Preziosi M, Russell JO, Alvarado TF, Oertel M, Nejak-Bowen KN, Zhang Y, Monga SP.

J Hepatol. 2015 Feb;62(2):380-7. doi: 10.1016/j.jhep.2014.10.021. Epub 2014 Oct 18.

PMID:
25457204
5.

The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells.

Cao C, Sun J, Zhang D, Guo X, Xie L, Li X, Wu D, Liu L.

Gastroenterology. 2015 Feb;148(2):415-26.e18. doi: 10.1053/j.gastro.2014.10.012. Epub 2014 Oct 22.

PMID:
25449213
6.

[Expression of β-catenin and HNF-1α and their influence on prognosis in human hepatocellular carcinoma].

Shi J, Yin F.

Zhonghua Zhong Liu Za Zhi. 2014 Aug;36(8):587-91. Chinese.

PMID:
25430024
7.

Metadata checklist: identification of CHI3L1 and MASP2 as a biomarker pair for liver cancer through integrative secretome and transcriptome analysis.

Ding W, Qiu Q, Liu G, Liu J, Mao R, Lin B.

OMICS. 2014 Oct;18(10):658-61. doi: 10.1089/omi.2014.0090. Epub 2014 Aug 18. No abstract available.

PMID:
25133456
8.

Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying β-catenin degradation.

Yuan R, Wang K, Hu J, Yan C, Li M, Yu X, Liu X, Lei J, Guo W, Wu L, Hong K, Shao J.

Cancer Res. 2014 Sep 15;74(18):5287-300. doi: 10.1158/0008-5472.CAN-14-0284. Epub 2014 Jul 23.

PMID:
25056121
9.

β-catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma.

Lu LC, Shao YY, Lee YH, Hsieh MS, Hsiao CH, Lin HH, Kao HF, Ma YY, Yen FC, Cheng AL, Hsu CH.

Oncology. 2014;87(3):159-66. doi: 10.1159/000362821. Epub 2014 Jul 8.

PMID:
25012536
10.

SOX10 is a novel oncogene in hepatocellular carcinoma through Wnt/β-catenin/TCF4 cascade.

Zhou D, Bai F, Zhang X, Hu M, Zhao G, Zhao Z, Liu R.

Tumour Biol. 2014 Oct;35(10):9935-40. doi: 10.1007/s13277-014-1893-1. Epub 2014 Jul 8.

PMID:
25001176
11.

14-3-3σ induces heat shock protein 70 expression in hepatocellular carcinoma.

Liu CC, Jan YJ, Ko BS, Wu YM, Liang SM, Chen SC, Lee YM, Liu TA, Chang TC, Wang J, Shyue SK, Sung LY, Liou JY.

BMC Cancer. 2014 Jun 12;14:425. doi: 10.1186/1471-2407-14-425.

12.

Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.

Fatima S, Luk JM, Poon RT, Lee NP.

Expert Rev Mol Diagn. 2014 Jun;14(5):535-48. doi: 10.1586/14737159.2014.915747. Epub 2014 May 9. Review.

PMID:
24809435
13.

Transcriptomic characterization of hepatocellular carcinoma with CTNNB1 mutation.

Ding X, Yang Y, Han B, Du C, Xu N, Huang H, Cai T, Zhang A, Han ZG, Zhou W, Chen L.

PLoS One. 2014 May 5;9(5):e95307. doi: 10.1371/journal.pone.0095307. eCollection 2014.

14.

Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver.

Okumura A, Unoki-Kubota H, Matsushita Y, Shiga T, Moriyoshi Y, Yamagoe S, Kaburagi Y.

Biosci Trends. 2013 Dec;7(6):276-83.

15.

DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.

Chen L, Li M, Li Q, Wang CJ, Xie SQ.

Mol Cancer. 2013 Dec 10;12:157. doi: 10.1186/1476-4598-12-157.

16.

Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment.

Chen CK, Yang CY, Hua KT, Ho MC, Johansson G, Jeng YM, Chen CN, Chen MW, Lee WJ, Su JL, Lai TC, Chou CC, Ho BC, Chang CF, Lee PH, Chang KJ, Hsiao M, Lin MT, Kuo ML.

Hepatology. 2014 Mar;59(3):974-85. doi: 10.1002/hep.26738. Epub 2014 Jan 16. Erratum in: Hepatology. 2014 May;59(5):2058. Hua, Kuo-Ti [corrected to Hua, Kuo-Tai].

PMID:
24114941
17.

Identification and expression analysis of the leukocyte cell-derived chemotaxin-2 (LECT2) gene in duck (Anas platyrhynchos).

Xu Q, Chen Y, Tong YY, Huang ZY, Zhao WM, Duan XJ, Zhang Y, Li X, Chang GB, Chen GH.

Gene. 2014 Jan 1;533(1):280-5. doi: 10.1016/j.gene.2013.09.047. Epub 2013 Sep 26.

PMID:
24076354
18.

β-Catenin signaling in hepatocellular cancer: Implications in inflammation, fibrosis, and proliferation.

Lee JM, Yang J, Newell P, Singh S, Parwani A, Friedman SL, Nejak-Bowen KN, Monga SP.

Cancer Lett. 2014 Feb 1;343(1):90-7. doi: 10.1016/j.canlet.2013.09.020. Epub 2013 Sep 23.

19.

β-Catenin knockdown in liver tumor cells by a cell permeable gamma guanidine-based peptide nucleic acid.

Delgado E, Bahal R, Yang J, Lee JM, Ly DH, Monga SP.

Curr Cancer Drug Targets. 2013 Oct;13(8):867-78.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk